グリア細胞系由来神経栄養因子(GDNF)タンパク質産物を使用するアルツハイマー病の治療方法

Title:

グリア細胞系由来神経栄養因子(GDNF)タンパク質産物を使用するアルツハイマー病の治療方法

Document Type and Number:

Japanese Patent JP4761409

Kind Code:

B2

Abstract:

The present invention relates generally to methods for treating injury or degeneration of basal forebrain cholinergic neurons by administering glial cell line-derived neurotrophic factor (GDNF). The invention relates specifically to methods for treating Alzheimer's disease.

More Like This:

JP2956788	[Title of the Invention] A spiroisoindoline compound, a method for producing the same, a drug for treating neurosis containing the spiroisoindoline compound, and an intermediate for producing the same.
WO/2001/070204	HIGHLY SELECTIVE INHIBITORS OF THE UROKINASE PLASMINOGEN ACTIVATOR
WO/2012/016978	GLYCOLIPID FOR TREATMENT OF ISCHEMIA REPERFUSION INJURY

Inventors:

Williams, Lawrence Earl

Application Number:

JP51357297A

Publication Date:

August 31, 2011

Filing Date:

September 23, 1996

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Amjien Incorporated

International Classes:

A61K31/00; A61K38/00; C12N15/09; A61K38/18; A61K38/22; A61P25/28; C07K14/00; C07K14/52; C12N5/10; C12P21/02

Domestic Patent References:

JP7502980A
JP9510620A

Foreign References:

WO1995017203A1

Attorney, Agent or Firm:

Yoshio Kawaguchi
Katsuma Osaki
Kuramochi Akiko
Atsushi Okamoto

Previous Patent: 逆止弁及びこれを備えた収納体

Next Patent: ダイクッション装置